703796003: Ponatinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Ponatinib

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Ponatinib

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Ponatinib

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Ponatinib

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3009418013 Ponatinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3009711015 Ponatinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

366141000195115 ponatinib it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

834651000172115 ponatinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ponatinib	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Ponatinib	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Ponatinib	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Ponatinib	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Ponatinib	Is a	Benzamide (substance)	false	Inferred relationship	Some
Ponatinib	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Ponatinib	Is a	Substance with benzamide structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ponatinib hydrochloride (substance)	Is a	False	Ponatinib	Inferred relationship	Some
Product containing ponatinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ponatinib	Inferred relationship	Some	1
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ponatinib	Inferred relationship	Some	1
Ponatinib (as ponatinib hydrochloride) 45 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ponatinib	Inferred relationship	Some	1
Ponatinib-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ponatinib	Inferred relationship	Some	1
Ponatinib hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Ponatinib	Inferred relationship	Some
Product containing only ponatinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ponatinib	Inferred relationship	Some	1
Ponatinib only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ponatinib	Inferred relationship	Some	1
Product containing precisely ponatinib (as ponatinib hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ponatinib	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set